S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

Forbion European Acquisition Stock Price, News & Analysis (NASDAQ:FRBN)

$21.70
-0.87 (-3.85%)
(As of 10/31/2023)
Compare
Today's Range
$17.00
$22.23
50-Day Range
$9.90
$28.44
52-Week Range
$9.25
$47.17
Volume
60,900 shs
Average Volume
140,023 shs
Market Capitalization
$343.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

FRBN stock logo

About Forbion European Acquisition Stock (NASDAQ:FRBN)

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.

FRBN Stock Price History

FRBN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive FRBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forbion European Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:FRBN
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$343.08 million
Optionable
Not Optionable
Beta
-0.36
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report














FRBN Stock Analysis - Frequently Asked Questions

How have FRBN shares performed in 2023?

Forbion European Acquisition's stock was trading at $10.33 at the beginning of the year. Since then, FRBN shares have increased by 110.1% and is now trading at $21.70.
View the best growth stocks for 2023 here
.

Who are Forbion European Acquisition's major shareholders?

Forbion European Acquisition's stock is owned by a variety of institutional and retail investors. Top institutional investors include Cowen AND Company LLC (4.68%), Periscope Capital Inc. (4.30%), Westchester Capital Management LLC (3.23%), Radcliffe Capital Management L.P. (1.60%), Shaolin Capital Management LLC (1.51%) and Mizuho Securities USA LLC (0.95%).

How do I buy shares of Forbion European Acquisition?

Shares of FRBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:FRBN) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -